Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial adhesion to intestinal epithelial cells is a biological process, not a single protein or canonical drug target, referring to how bacteria—both pathogenic and probiotic species—attach to the mucosal surface or directly to epithelial cells in the gastrointestinal tract[1][2][7]. Adhesion is mediated by diverse bacterial structures (adhesins, surface-layer proteins, pili/fimbriae), which bind to host molecules such as mucins, E-cadherin, collagen, and other extracellular matrix proteins[1][2][3][6]. This process is essential for microbial colonization, immune system interaction, and, in the case of pathogens, invasion and disease. In probiotics, adhesion is often linked to beneficial colonization and competition with pathogens[1][2].
Inhibition of adhesins; Disruption of bacterial surface proteins or host cell receptors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial adhesion to intestinal epithelial cells.